Abiopharma

🔍 Volpi Michelangelo (Executive)

Company: Aurora Innovation, Inc. (AUR)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 1,511,093 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: C | equity_swap_involved: false | shares_owned_after: 1,826,508.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,826,508 shares of Class A Common Stock at $7.0523 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 23,011 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: C | equity_swap_involved: false | shares_owned_after: 27,814.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 27,814 shares of Class A Common Stock at $7.0523 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 908,784 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: G | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5
• Acquired 34,181 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: C | equity_swap_involved: false | shares_owned_after: 34,181.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 34,181 shares of Class A Common Stock at $7.0004 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F6, F2
• Acquired 520 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: C | equity_swap_involved: false | shares_owned_after: 520.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 520 shares of Class A Common Stock at $7.0004 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F6, F4
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By: The M. Volpi 2025 GRAT 2 | shares_owned_after: 943,067.00 | Footnotes: F7
• Sold 1,511,093 shares of Class B Common Stock (Derivative)
  Date: 2026-08-07 | Code: C | equity_swap_involved: false | shares_owned_after: 35,831,901.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 23,011 shares of Class B Common Stock (Derivative)
  Date: 2026-08-07 | Code: C | equity_swap_involved: false | shares_owned_after: 545,643.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F4
• Sold 34,181 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: C | equity_swap_involved: false | shares_owned_after: 35,797,720.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
• Sold 520 shares of Class B Common Stock (Derivative)
  Date: 2026-08-10 | Code: C | equity_swap_involved: false | shares_owned_after: 545,123.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F4

Footnotes:

• F1: The shares of Class B Common Stock are convertible at any time at the option of the holder into shares of Class A Common Stock on a one-for-one basis, subject to certain exceptions, and automatically convert into Class A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
• F2: Shares held by Index Ventures Growth III (Jersey) L.P. ("Index Growth III"). Index Venture Growth Associates III Limited ("IVGA III") is the managing general partner of Index Growth III. The Reporting Person is a retired partner within the Index Ventures group. Advisors within the Index Ventures group provide advice to Index Growth III. The Reporting Person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
• F3: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.1399. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the range set forth above.
• F4: Shares held by Yucca (Jersey) SLP ("Yucca"). Yucca is the administrator of the Index co-investment vehicles that are contractually required to mirror the relevant fund's investment in the issuer (in this case, Index Growth III). The Reporting Person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
• F5: Reflects the transfer of 908,784 shares of Class A Common Stock as a bona fide gift to a charitable donor-advised fund on August 10, 2026. There was no purchase or sale of shares of Class A Common Stock in connection with the gift.
• F6: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.015. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the range set forth above.
• F7: Shares held by The M. Volpi 2025 GRAT 2 (the "2025 GRAT"), a grantor-retained annuity trust for which the Reporting Person is the trustee and sole annuitant.
• REMARKS: Exhibit 24 - Power of Attorney